DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Wedemeyer H, Port K, Deterding K. et al.
A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study.
Journal Of Hepatology 2017;
66: S24
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.